By Barbara Stephenson Posted April 21, 2020 InCRC2020-04-212021-03-03https://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.pngCofactor Genomicshttps://cofactorgenomics.com/wp-content/uploads/2016/10/cofactor_logo_dark.png200px200px CRCRecent PostsCofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain SpinoutCulmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical TrialTop 100 in Cancer – 2022Cofactor Genomics Opens Enrollment for Non-small Cell Lung Cancer Study of OncoPrism Predictive Diagnostic Assay